Tao Huang

2 months ago | mdpi.com | Tao Huang |Yarong Liu |Xin Liu Liu |Meng Wang

1. IntroductionWireless communication’s openness and shared nature provide users with easy access and connectivity benefits. Nevertheless, these advantages also expose communication networks to the wireless environment, making them more susceptible to jamming attacks compared to wired networks [1].

2 months ago | jamanetwork.com | Tao Huang |Alessandro Bosi |Anne-Laure Faucon |Morgan E. Grams

Error in Figure and Results GLP-1RA vs DPP-4i Use and Hyperkalemia and RAS Blockade Discontinuation Tao Huang, MSc; Alessandro Bosi, MSc; Anne-Laure Faucon, MD, PhD; Morgan E. Grams, MD, PhD; Arvid Sjölander, PhD; Edouard L.

Oct 23, 2024 | nature.com | Tao Huang

AbstractThis study evaluates the survival outcomes of segmental ureterectomy (SU) combined with chemotherapy in patients with high-grade non-metastatic ureteral cancer (UC) using data from the SEER database. A total of 1757 patients with Grade III-IV non-metastatic UC were analyzed. Overall survival (OS) was assessed through Kaplan–Meier analysis, and independent prognostic factors were identified via Cox regression.

Sep 23, 2024 | mdpi.com | Tao Huang |Xiaolong Alan Zhou |Ke He |Meina Fei

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Aug 12, 2024 | jamanetwork.com | Tao Huang |Alessandro Bosi |Morgan E. Grams

Key PointsQuestion  Is the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) vs dipeptidyl peptidase-4 inhibitors (DPP-4is) associated with different rates of hyperkalemia or prolonged renin-angiotensin system (RAS) inhibitor use in people with type 2 diabetes (T2D)? Findings  In this cohort study of 33 280 patients with T2D, the use of GLP-1RAs was associated with a lower rate of hyperkalemia and prolonged RAS inhibitor use compared with the use of DPP-4is.